Years of experience: 27

PartnerInvestor & VCC-level ExecutiveSales & BizDevCEOConsulting

Trust Score

Exceptionally trusted; proven professional excellence.

80%
Soren's Career Path
Chief Business OfficerDec. 2024 -
Feb. 2025
Axcynsis TherapeuticsChief Business Officer
New York City Metropolitan AreaLeading Axcynsis' $40M series A fundraising and supporting partnering of its proprietary, first-in-class AxcynDOT payload and IND-stage ADC therapeutics
Director Board of DirectorsMay. 2023 -
Apr. 2024
PILA PHARMADirector Board of Directors
Malmö, Skåne County, SwedenDirector on the board with special insights into orphan drug development and US opportunities
Chief Executive OfficerDec. 2020 -
Apr. 2024
DeckTherapeutics, Inc.Chief Executive Officer
New York City Metropolitan AreaLed Columbia University spinout DeckTherapeutics on its mission to pioneer neuroprotection using intravenous omega-3 diglyceride therapeutics. Secured funding from two institutional investors and a non-dilutive grant from the Bill & Melinda Gates Foundation. Oversaw the progression of the lead asset to late preclinical stage.